Pacira Biosciences, Inc. is a pharmaceutical company based in the United States that focuses on providing non-opioid pain management and regenerative health solutions. With an ESG score of 27.7, the company is considered to have a medium risk assessment. Pacira BioSciences Inc. offers three commercialized non-opioid treatments, including EXPAREL, ZILRETTA, and iovera, aimed at improving outcomes for healthcare practitioners and their patients.